Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCMVtight-UPRT-T2A-RFP-IRES-CD Citations (2)

Originally described in: Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization.
Basnet H, Tian L, Ganesh K, Huang YH, Macalinao DG, Brogi E, Finley LW, Massague J Elife. 2019 Mar 26;8. pii: 43627. doi: 10.7554/eLife.43627.
PubMed Journal

Articles Citing pCMVtight-UPRT-T2A-RFP-IRES-CD

Articles
Quantitative evaluation and comparison of two prodrug-activating suicide gene therapies on oral squamous cell carcinoma. Xu N, Tian H, Fung CP, Lin Y, Zhu G, Shen Y, Yang H. Am J Cancer Res. 2021 Apr 15;11(4):1672-1682. eCollection 2021. PubMed
Inhibition of human oral squamous cell carcinoma proliferation and migration by prodrug-activating suicide gene therapies. Xu N, Tian H, Po Fung C, Lin Y, Chen Y, Zhu G, Shen Y, Guo C, Yang H. Exp Ther Med. 2023 Jan 9;25(2):92. doi: 10.3892/etm.2023.11790. eCollection 2023 Feb. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.